Chemical Compound Review:
AC1NSWUD (2Z)-2-(2-oxo-1H-indol-3- ylidene)-1H-indol...
Synonyms:
SureCN9899338, BSPBio_001110, BMK1-G9, Ambotz479-41-4, CHEBI:150286, ...
- Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Hoessel, R., Leclerc, S., Endicott, J.A., Nobel, M.E., Lawrie, A., Tunnah, P., Leost, M., Damiens, E., Marie, D., Marko, D., Niederberger, E., Tang, W., Eisenbrand, G., Meijer, L. Nat. Cell Biol. (1999)
- Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Nam, S., Buettner, R., Turkson, J., Kim, D., Cheng, J.Q., Muehlbeyer, S., Hippe, F., Vatter, S., Merz, K.H., Eisenbrand, G., Jove, R. Proc. Natl. Acad. Sci. U.S.A. (2005)
- Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? Leclerc, S., Garnier, M., Hoessel, R., Marko, D., Bibb, J.A., Snyder, G.L., Greengard, P., Biernat, J., Wu, Y.Z., Mandelkow, E.M., Eisenbrand, G., Meijer, L. J. Biol. Chem. (2001)
- 7-Bromoindirubin-3'-oxime induces caspase-independent cell death. Ribas, J., Bettayeb, K., Ferandin, Y., Knockaert, M., Garrof??-Ochoa, X., Totzke, F., Sch??chtele, C., Mester, J., Polychronopoulos, P., Magiatis, P., Skaltsounis, A.L., Boix, J., Meijer, L. Oncogene (2006)
- Characterization of a forest soil metagenome clone that confers indirubin and indigo production on Escherichia coli. Lim, H.K., Chung, E.J., Kim, J.C., Choi, G.J., Jang, K.S., Chung, Y.R., Cho, K.Y., Lee, S.W. Appl. Environ. Microbiol. (2005)
- Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3. Hongisto, V., Smeds, N., Brecht, S., Herdegen, T., Courtney, M.J., Coffey, E.T. Mol. Cell. Biol. (2003)
- Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest. Damiens, E., Baratte, B., Marie, D., Eisenbrand, G., Meijer, L. Oncogene (2001)
- Induction of differentiation and down-regulation of c-myb gene expression in ML-1 human myeloblastic leukemia cells by the clinically effective anti-leukemia agent meisoindigo. Liu, X.M., Wang, L.G., Li, H.Y., Ji, X.J. Biochem. Pharmacol. (1996)
- Indigo production by naphthalene-degrading bacteria. Bhushan, B., Samanta, S.K., Jain, R.K. Lett. Appl. Microbiol. (2000)
- Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappaB signaling pathway. Sethi, G., Ahn, K.S., Sandur, S.K., Lin, X., Chaturvedi, M.M., Aggarwal, B.B. J. Biol. Chem. (2006)
- Antitumor activity of novel indirubin derivatives in rat tumor model. Kim, S.A., Kim, Y.C., Kim, S.W., Lee, S.H., Min, J.J., Ahn, S.G., Yoon, J.H. Clin. Cancer Res. (2007)
- Comparison of gene expression patterns between 2,3,7,8-tetrachlorodibenzo-p-dioxin and a natural arylhydrocarbon receptor ligand, indirubin. Adachi, J., Mori, Y., Matsui, S., Matsuda, T. Toxicol. Sci. (2004)
- Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine. Eisenbrand, G., Hippe, F., Jakobs, S., Muehlbeyer, S. J. Cancer Res. Clin. Oncol. (2004)
- Inhibition of RANTES expression by indirubin in influenza virus-infected human bronchial epithelial cells. Mak, N.K., Leung, C.Y., Wei, X.Y., Shen, X.L., Wong, R.N., Leung, K.N., Fung, M.C. Biochem. Pharmacol. (2004)
- Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin. Spink, B.C., Hussain, M.M., Katz, B.H., Eisele, L., Spink, D.C. Biochem. Pharmacol. (2003)
- Indirubin, a Chinese anti-leukaemia drug, promotes neutrophilic differentiation of human myelocytic leukaemia HL-60 cells. Suzuki, K., Adachi, R., Hirayama, A., Watanabe, H., Otani, S., Watanabe, Y., Kasahara, T. Br. J. Haematol. (2005)
- Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity. Kunikata, T., Tatefuji, T., Aga, H., Iwaki, K., Ikeda, M., Kurimoto, M. Eur. J. Pharmacol. (2000)
- Generation of new protein kinase inhibitors utilizing cytochrome p450 mutant enzymes for indigoid synthesis. Guengerich, F.P., Sorrells, J.L., Schmitt, S., Krauser, J.A., Aryal, P., Meijer, L. J. Med. Chem. (2004)
- Characterization of dark liver pigment observed in rats after subchronic dosing of the beta3-adrenergic receptor agonist LY368842. He, M.M., Barbuch, R.J., Abraham, T.L., Lindsay, T.J., Jackson, D.A., Ackermann, B.L., Wilke, A.V., Jensen, C.B. Chem. Res. Toxicol. (2003)
- Identification of an indigo precursor from leaves of Isatis tinctoria (Woad). Maugard, T., Enaud, E., Choisy, P., Legoy, M.D. Phytochemistry (2001)
- Novel indole S,O-bisdesmoside, calanthoside, the precursor glycoside of tryptanthrin, indirubin, and isatin, with increasing skin blood flow promoting effects, from two Calanthe species (Orchidaceae). Yoshikawa, M., Murakami, T., Kishi, A., Sakurama, T., Matsuda, H., Nomura, M., Matsuda, H., Kubo, M. Chem. Pharm. Bull. (1998)
- Protein engineering of toluene ortho-monooxygenase of Burkholderia cepacia G4 for regiospecific hydroxylation of indole to form various indigoid compounds. Rui, L., Reardon, K.F., Wood, T.K. Appl. Microbiol. Biotechnol. (2005)
- Aryl hydrocarbon receptor-mediated induction of microsomal drug-metabolizing enzyme activity by indirubin and indigo. Sugihara, K., Kitamura, S., Yamada, T., Okayama, T., Ohta, S., Yamashita, K., Yasuda, M., Fujii-Kuriyama, Y., Saeki, K., Matsui, S., Matsuda, T. Biochem. Biophys. Res. Commun. (2004)
- Studies on the mechanism of indirubin action in the treatment of chronic granulocytic leukemia. V. Binding between indirubin and DNA and identification of the type of binding. Wu, G.Y., Liu, J.Z., Fang, F.D., Zuo, J. Sci. Sin., Ser. B, Chem. Biol. Agric. Med. Earth Sci. (1982)
- Identification of indigo-related pigments produced by Escherichia coli containing a cloned Rhodococcus gene. Hart, S., Koch, K.R., Woods, D.R. J. Gen. Microbiol. (1992)